Completed PHASE3 INTERVENTIONAL 2-arm NCT00933049

Cotrimoxazole Versus Amoxicillin in the Treatment of Community Acquired Pneumonia in Children Aged 2-59 Months

Clinical Efficacy of Cotrimoxazole Versus Amoxicillin in the Treatment of Community Acquired Pneumonia in Children Aged 2-59 Months Attending Mulago Hospital: A Randomized Clinical Trial.

Sponsor: Makerere University

Conditions Childhood Pneumonia

Interventions Amoxicillin Amoxicillin placebo Cotrimoxazole Cotrimoxazole placebo

Updated 5 times since 2017 Last updated: Jul 6, 2009 Started: Jul 31, 2007 Primary completion: Jan 31, 2008 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Childhood Pneumonia, this trial is completed. The trial is conducted by Makerere University and has accumulated 5 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Makerere University

Data source: Makerere University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kampala, Uganda